Horizon Kinetics Medical ETF Rating $31.78 +0.25 (+0.81%) Closing price 10/3/2025 03:50 PM EasternExtended Trading$31.78 +0.00 (+0.00%) As of 10/3/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsShort InterestTrendsBuy This Stock Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MEDX Aggregate RatingModerate Buy 2.59Holdings in MEDX have an aggregate rating of Moderate Buy based on 379 analyst ratings issued in the past year covering 23 companies (81.9% of the portfolio).MEDX Aggregate Price Target$31.78High Prediction$31.78Average Prediction$31.78Low Prediction$31.78Holdings in MEDX have an aggregate price target of $31.78 and a range of $31.78 to $31.78 covering 23 companies (81.9% of the portfolio).MEDX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Horizon Kinetics Medical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 MEDX Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings14.34%LLYEli Lilly and Company$840.46+2.5%4.9893 of 5 stars2.64$933.39 11.1%25Trending NewsAnalyst ForecastOptions Volume9.77%ABBVAbbVie$234.07-1.1%4.6279 of 5 stars2.83$228.22 -2.5%30Trending NewsAnalyst Downgrade6.44%ALNYAlnylam Pharmaceuticals$456.35-1.0%4.1038 of 5 stars2.79$439.58 -3.7%29Trending NewsAnalyst UpgradeInsider Trade4.98%AZNAstraZeneca$85.31+2.0%2.9926 of 5 stars2.80$86.00 0.8%5Options Volume4.85%JNJJohnson & Johnson$188.51+1.4%4.6931 of 5 stars2.68$187.47 -0.6%22Trending NewsAnalyst Forecast4.46%IONSIonis Pharmaceuticals$69.15+1.1%3.3795 of 5 stars2.78$73.88 6.8%18Trending NewsInsider Trade4.30%BMYBristol Myers Squibb$45.39-0.7%4.9814 of 5 stars2.26$56.38 24.2%23Positive NewsAnalyst UpgradeOptions Volume3.87%AMGNAmgen$297.89+0.2%4.5603 of 5 stars2.29$309.70 4.0%21Positive NewsAnalyst Upgrade3.66%CRSPCRISPR Therapeutics$67.74-7.0%1.8079 of 5 stars2.42$71.50 5.6%193.65%ALKSAlkermes$31.06-0.6%4.5142 of 5 stars2.93$42.00 35.2%143.57%PFEPfizer$27.37+1.1%4.8743 of 5 stars2.37$28.41 3.8%19Trending NewsAnalyst Forecast3.07%MRKMerck & Co., Inc.$89.25-0.3%4.9957 of 5 stars2.32$106.41 19.2%22Positive NewsOptions Volume2.61%GSKGSK$43.30-0.9%2.1808 of 5 stars1.88$37.38 -13.7%8Dividend CutHigh Trading Volume2.48%BIIBBiogen$159.88+3.0%4.454 of 5 stars2.32$181.24 13.4%312.34%REGNRegeneron Pharmaceuticals$600.004.7536 of 5 stars2.79$817.67 36.3%29Positive NewsAnalyst Revision1.48%GALTGalectin Therapeutics$4.33+1.9%1.4558 of 5 stars2.00$6.00 38.6%2Gap Up1.40%NTLAIntellia Therapeutics$19.96-2.3%4.3922 of 5 stars2.45$27.39 37.2%20Gap Up1.30%BEAMBeam Therapeutics$25.75+0.6%3.113 of 5 stars2.93$46.40 80.2%140.72%HLNHaleon$8.94+0.6%4.2566 of 5 stars2.50$12.33 37.9%10Positive News0.70%VNDAVanda Pharmaceuticals$5.43+5.2%4.2845 of 5 stars2.67$16.50 203.9%3High Trading Volume0.67%LTRNLantern Pharma$4.11+2.2%2.0597 of 5 stars2.00$25.00 508.3%2News Coverage0.66%SDZNYSandoz Group$58.41+1.3%2.4012 of 5 stars2.003Positive News0.58%BCYCBicycle Therapeutics$8.37-1.9%3.8093 of 5 stars2.50$22.22 165.5%10Options Volume This page (NASDAQ:MEDX) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredURGENT: The Market's 3 Red Flags Are FlashingThe warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gol...StockEarnings | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Horizon Kinetics Medical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Horizon Kinetics Medical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
